Giuseppe Lombardi

Lombardi Giuseppe: Prospective study on regorafenib in recurrent glioblastoma

Lombardi Giuseppe, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared on X:

“Finally out!! 30 Italian centers and 190 patients enrolled: what an incredible effort for this prospective study on regorafenib in recurrent glioblastoma! Thanks to all of the collaborators!!”

 

Lombardi Giuseppe: Prospective study on regorafenib in recurrent glioblastoma

Proceed to the article.
Source: Lombardi Giuseppe/X

cancer glioblastoma Lombardi Giuseppe Neuro-Oncology OncoDaily Oncology recurrent glioblastoma regorafenib Veneto Institute of Oncology